** Shares of Bluechiip Ltd BCT.AX rise as much as 30.4% to
A$0.073, their highest since Sept 16, 2020
** The wireless tracking devices maker says it received
product registration from the United States Food and Drug
Administration (FDA) and a CE IVD certification from the
European Union urn:newsml:reuters.com:*:nASXmfQqh
** The CE certification for in vitro diagnostic devices
means that the device may be legally commercialized in the EU
** Says the registrations imply Bluechiip can sell products
and deliver software consumables directly into the United
States, Europe and the Asia/Pacific region
** Shares on track for their best day since Oct 26
** At 20.7 mln, volumes are 3.7 times the 30-day average of
5.5 mln shares
** As of last close, stock up 27.3% this year
(Reporting by Himanshi Akhand in Bengaluru)
((Himanshi.Akhand@thomsonreuters.com;))